Susceptibility to antimicrobials and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae from Rio de Janeiro, Brazil

References

1. Centers for Disease Control and Prevention; 1996; Prevention of perinatal group B streptococcal disease: a public health perspective. Morb Mortal Wkly Rep 45 (RR-7):1–24
   [Google Scholar]
2. de Azavedo J. C. S., McGavin M, Duncan C, Low D. E, McGeer A. 2001; Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45:3504–3508 [CrossRef]
   [Google Scholar]
3. d'Oliveira R. E. C, Barros R. R, Mendonça C. R. V, Teixeira L. M, Castro A. C. D. 2003; Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro. Brazil. Microb Drug Resist 9:87–91 [CrossRef]
   [Google Scholar]
4. Fernandez M, Hickman M. E, Baker C. J. 1998; Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 42:1517–1519
   [Google Scholar]
5. Hsueh P.-R, Teng L.-J, Lee L.-N, Ho S.-W, Yang P.-C, Luh K.-T. 2001; High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 45:3205–3208 [CrossRef]
   [Google Scholar]
6. Muñoz P, Llancaqueo A, Rodríguez-Créixems M, Peláez T, Martin L, Bouza E. 1997; Group B streptococcus bacteremia in nonpregnant adults. Arch Intern Med 157:213–216 [CrossRef]
   [Google Scholar]
7. National Committee for Clinical Laboratory Standards 2000a Performance Standards for Antimicrobial Disk Susceptibility Tests, 7th edn. Approved standard M2-A7 Wayne, PA: NCCLS;
   [Google Scholar]
8. National Committee for Clinical Laboratory Standards 2000b Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically , 5th edn. Approved standard M7-A5 Wayne, PA: NCCLS;
   [Google Scholar]
9. Seppälä H, Nissinen A, Yu Q, Huovinen P. 1993; Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32:885–891 [CrossRef]
   [Google Scholar]
10. Seppälä H, Skurnik M, Soini H, Roberts M. C, Huovinen P. 1998; A novel erythromycin resistance methylase gene ( ermTR ) in Streptococcus pyogenes . Antimicrob Agents Chemother 42:257–262 [CrossRef]
    [Google Scholar]
11. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. 1996; Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40:2562–2566
    [Google Scholar]
12. Traub W. H, Leonhard B. 1997; Comparative susceptibility of clinical group A, B, C, F, and G β-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43:10–20 [CrossRef]
    [Google Scholar]